Pulmonary Diseases Withdrawn Phase 3 Trials for Hydroxychloroquine (DB01611)

Also known as: Disease, Pulmonary / Pulmonary Disease

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04361461Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)Treatment